KEY FEATURES
| Full Name | Chemokine C-X3-C-Motif Receptor 1 |
|---|---|
| Synonym | CCRL1; CMKBRL1; CMKDR1; GPR13; GPRV28; V28; Beta chemokine receptor-like 1; Fractalkine receptor; G-protein coupled receptor 13 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.07ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CX3CR1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CX3CR1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CX3CR1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CX3CR1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CX3CR1. You can calculate the concentration of Human CX3CR1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CX3CR1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.47 | 1.44 | 4.31 | 0.48 | 1.42 | 4 |
| Standard deviation | 0.03 | 0.08 | 0.16 | 0.03 | 0.07 | 0.15 |
| CV(%) | 6.69 | 5.69 | 3.75 | 5.33 | 5.19 | 3.69 |
RECOVERY
The recovery of Human CX3CR1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-108 | 98 |
| EDTA plasma (n=8) | 92-104 | 97 |
| Cell culture media (n=8) | 89-103 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CX3CR1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FKN ELISA Kits
| CX3CL1 ELISA Kit | publications with FKN and CX3CL1 |
| CCL2 ELISA Kit | publications with FKN and CCL2 |
| CXCL12 ELISA Kit | publications with FKN and CXCL12 |
| CCL5 ELISA Kit | publications with FKN and CCL5 |
| CXCL10 ELISA Kit | publications with FKN and CXCL10 |
| CCL22 ELISA Kit | publications with FKN and CCL22 |
| CCL17 ELISA Kit | publications with FKN and CCL17 |
| CCL21 ELISA Kit | publications with FKN and CCL21 |
| CCL26 ELISA Kit | publications with FKN and CCL26 |
| CCL13 ELISA Kit | publications with FKN and CCL13 |
Pathways associated with FKN ELISA Kit
| Chemokine Receptors Bind Chemokines Pathway | Chemokine Receptors Bind Chemokines Pathway |
| Chemokine Signaling Pathway | Chemokine Signaling Pathway |
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
| GPCRs, Class A Rhodopsin-like Pathway | GPCRs, Class A Rhodopsin-like Pathway |
| Peptide GPCRs Pathway | Peptide GPCRs Pathway |
| Peptide Ligand-binding Receptors Pathway | Peptide Ligand-binding Receptors Pathway |
Diseases associated with FKN ELISA Kit
| Inflammation | publications with FKN and Inflammation |
| Disease Models, Animal | publications with FKN and Disease Models, Animal |
| Cardiovascular Diseases | publications with FKN and Cardiovascular Diseases |
| Necrosis | publications with FKN and Necrosis |
| Atherosclerosis | publications with FKN and Atherosclerosis |
| Neoplasms | publications with FKN and Neoplasms |
| HIV Infections | publications with FKN and HIV Infections |
| Kidney Diseases | publications with FKN and Kidney Diseases |
| Coronary Disease | publications with FKN and Coronary Disease |
| Liver Diseases | publications with FKN and Liver Diseases |
Organs/Tissues associated with FKN ELISA Kit
| Blood | publications with FKN and Blood |
| Brain | publications with FKN and Brain |
| Lung | publications with FKN and Lung |
| Kidney | publications with FKN and Kidney |
| Spinal Cord | publications with FKN and Spinal Cord |
| Liver | publications with FKN and Liver |
| Spleen | publications with FKN and Spleen |
| Pancreas | publications with FKN and Pancreas |
| Connective Tissue | publications with FKN and Connective Tissue |
| Thymus | publications with FKN and Thymus |